KODIAK SCIENCES INC.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 |
|---|---|---|---|
| Revenue | — | — | — |
| Cost of Revenue | — | — | — |
| Gross Profit | — | — | — |
| Gross Margin | — | — | — |
| Operating Expenses | |||
| Research & Development | $18.8M | $22.0M | $14.1M |
| SG&A Expense | $7.6M | $3.5M | $3.1M |
| Operating Income | $-26.4M | $-25.5M | $-17.2M |
| Operating Margin | — | — | — |
| Interest Expense | $5.5M | $1.2M | $6.0K |
| Pretax Income | $-41.4M | $-27.9M | $-17.1M |
| Income Tax Expense | — | — | — |
| Net Income | $-41.4M | $-27.9M | $-17.1M |
| Net Margin | — | — | — |
| EPS (Basic) | $-2.77 | $-3.72 | $-2.38 |
| EPS (Diluted) | $-2.77 | $-3.72 | $-2.38 |
| Shares Outstanding (Basic) | 36.8M | 7.9M | — |
| Shares Outstanding (Diluted) | 36.8M | 7.9M | — |
| Dividends Per Share | — | — | — |